Genetic Testing & Biomarkers | 2025 Mid-Year Update | Todd Morgan, MD + Mark Moyad, MD Q&A скачать в хорошем качестве

Genetic Testing & Biomarkers | 2025 Mid-Year Update | Todd Morgan, MD + Mark Moyad, MD Q&A

Learn more about Dr. Todd Morgan here: https://medschool.umich.edu/profile/3... 4:03 3 Important questions 12:56 Diagnostic testing in prostate cancer 18:29 Who should undergo germline testing? 26:26 Highlights of the 3 gene expression classifier tests 32:35 Clinical trials 37:45 How do I use GEC tests? 41:34 Atera MMAI risk groups 43:43 Predictive signal for hormone therapy 45:09 AI take-home message 53:46 Overall take-home message 55:12 Dr. Moyad & Dr. Morgan Q&A To learn more about prostate cancer, visit http://www.pcri.org Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Donate to PCRI: https://pcri.org/donate/ Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.